Indeed, KDELR2 overexpression promotes the metastatic phenotype in non-small cell lung cancer (NSCLC) by increasing MMP1, MMP2 and MMP9 secretion and thus cell invasive ability (Bajaj et al., 2020). Here, MMP2 is linked to non-small cell lung carcinoma.